Test of LED System that Warns Drivers of Black Ice Under Way in Susono, Japan
2.3.2023 15:32:00 EET | Business Wire | Press release
Susono City, Stanley Electric Co., Ltd., Kaga FEI Co., Ltd., NTT Communications Corporation and Dassault Systèmes K.K.. announced jointly today that a system for warning drivers about transparent ("black") ice using a smart streetlight developed by the four companies is being tested on a public road in Susono, Japan from February 10 to March 31. The test will verify the effectiveness of the system in preventing car slippage and pedestrian falls in a public area of Susono.
For the test, a smart streetlight that projects an illuminated warning ("Caution Ice") on the road surface was installed on a light pole in front of Yanagibata Bridge in Ishiwaki, Susono City. During the test, data from an edge AI camera and sensors mounted on the smart streetlight are being collected and transmitted via mobile communication to a center for analysis, including by comparing the number of ice-related accidents at the site before and after the test. Also, residents will be surveyed to see if their awareness of ice-related hazards is changed by the operation of the system.
The roles of each company are as follow:
Stanley Electric:
- Develop, manufacture and supply LED streetlight and illumination-projection equipment
Kaga FEI:
- Provide edge AI camera and sensors
- Develop embedded AI system
NTT Communications:
- Implement mobile communications (IoT Connect Mobile® TypeS1)
- Provide platform for visualizing and storing collected data (Things Cloud®2)
Dassault Systèmes:
- Provide virtual twin3 platform (3DEXPERIENCE© platform)
- Build virtual twins, data visualization, and scenario analysis based on system and terrain data
Once the system is demonstrated to be fully reliable and effective, its broad deployment in other municipalities will be promoted along with the use of smart streetlights in emerging countries where road lighting is uncommon. In addition, by combining data from the system with weather data, etc., it will be possible to provide enhanced weather-related driving information, such as traffic congestion forecasts in areas where snow is expected, keeping drivers better informed while also supporting the work of road and traffic managers.
NTT Com's KOEL4 design studio will join the project to help research opportunities for commercial applications. It is expected that the system could be applied in business areas such as shopping malls and other commercial facilities as well as Park-PFI, a publicly solicited, privately financed initiative for the maintenance and management of urban parks in Japan.
Susono, which has adopted the slogan "Japan's most citizen-oriented city hall," is actively modernizing its urban areas through the introduction of universal-design pedestrian spaces, advanced technology and data analysis, aiming to realize zero fatalities and less than 200 injuries due to accidents per year by 2025.
1 IoT Connect Mobile® TypeS is an eSIM-based mobile data communication service.
2 Things Cloud® is an IoT platform that packages data collection, visualization, analysis and management functions via connected sensors and devices tailored to specific business environments.
3 Virtual twin, more than a digital copy of the real world, is a representation of the real world based on mathematical models and scientific principles.
4 The KOEL design studio was established in April 2020 within NTT Com's Innovation Center, which is dedicated to the creation of new businesses.
About Stanley Electric
Stanley Electric Co., Ltd. was founded in 1920 to manufacture and sell automotive light bulbs and other specialty light bulbs. Today, the company is highly regarded worldwide for products it supplies to major automobile manufacturers. Starting with the world's first commercial high-brightness LEDs in 1976, the company has developed numerous components and other electronic that contribute to safety and energy conservation, including smart streetlights. Please visit https://www.stanley.co.jp/
About Kaga FEI
Kaga FEI Co., Ltd. is an electronics trading company that sells consumer and industrial electronic devices and products for automobiles, AV equipment, communications equipment and information processing equipment. The company and its global partners also provide technical support and solution services that combine commercial products and technologies, including electronics manufacturing services, in markets worldwide. Please visit https://www.kagafei.com/jp/
About NTT Communications
NTT Communications solves global technology challenges by helping enterprises utilize managed IT-infrastructure solutions to overcome complexity and risk in their IT environments. These solutions are backed by our worldwide infrastructure, including industry-leading, global tier-1 public and private networks reaching over 190 countries/regions, and more than 500,000m2 of the world's most advanced data-center facilities. As the core provider of the DOCOMO group's enterprise-business services and solutions, we create value by providing global-scale support for restructuring in industry and society, new workstyles and digital transformation in communities. Together with NTT Ltd., NTT Data and NTT DOCOMO, we are the NTT Group.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com
About Dassault Systèmes
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating 'virtual twin experiences’ of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production.
Dassault Systèmes’ 20,000 employees are bringing value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit https://www.3ds.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230301006236/en/
Contact information
For more information
Susono
Business: Strategic Promotion Division
+81-55-995-1804; kikaku@city.susono.shizuoka.jp
Road management: Construction Management Division
+81-55-995-1855; kanri@city.susono.shizuoka.jp
Stanley Electric
Yokohama Technical Center, Lighting Application Division
+81-45-910-6629
Kaga FEI
Partner Business Promotion Department
System Business Center, Solutions Division
ml-snk_colbiz_pj@jp.kagafei.com
NTT Communications
Business Solution Division, Business Solution Department
bbx-5bs3g@ntt.com
Dassault Systèmes
Marketing Representative, Public Relations Division
+81-3-4321-3506; japan.marketing@3ds.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom